Genfit S.A. - GNFT

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2023 · Q1 2023
Value (USD)
Total reported value ($000)
$1.82M
QoQ value delta ($000)
-$1.15M (-38.72%)
Implied price effect (QoQ)
+6.02%
Shares
Total shares
515,393
QoQ shares delta
-376,257 (-42.2%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (GNFT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2023)

Top 25 only Full list
Early Q4 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Optiver Holding B.V. 1,050 296,612 0.0%
OLD MISSION CAPITAL LLC 297 84,033 0.01%
ENVESTNET ASSET MANAGEMENT INC 146 41,345 0.0%
MORGAN STANLEY 140 39,664 0.0%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 114 32,423 0.0%
TWO SIGMA INVESTMENTS, LP 50 14,365 0.0%
UBS Group AG 15 4,330 0.0%
BNP PARIBAS ARBITRAGE, SNC 6 1,800 0.0%
RHUMBLINE ADVISERS 2 803 0.0%
OSAIC HOLDINGS, INC. 0 18 0.0%